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Introduction
Glaucoma is a disease with characteristic changes of the
optic nerve, visual field and raised intra ocular pressure. Its
prevalence varies between, 1.6 to 8% and is dependent on the
ethnic composition of the population and it is one of the leading
causes of blindness in the developed world. There are  67 800
000 people worldwide suffering from glaucoma.1
In recent years, a number of highly potent topical
medications have been introduced. These have substantially
improved the conservative management of glaucoma. New laser
techniques are also being used and safer operative techniques
have been developed in order to cope with the more resistant
cases of glaucoma.
A previous study on ‘Glaucoma in Malta’, conducted in 1989,
established that 3% of Maltese population over the age of 40
suffers from glaucoma.2
This study was carried out in order to assess the
management of glaucoma patients in the Maltese Government
Health Service at the present time.
Methods
During the period from 1/7/2002 to 30/6/2003, a Glaucoma
Survey was carried out at St.Luke’s Hospital (SLH), Gozo
General Hospital and in the five Health Centres in Malta.
A specifically designed standard form was used by the doctors at
the outpatients department to record details of the visual functions
(Snellen visual acuity and central visual field carried out by one of
authors on Humphrey Visual Field Analyser), intraocular pressure,
type of glaucoma and details of its management.
 Other sources used were Schedule V database (which records
patients with chornic disease entitled to free medicines and the
medication they are on), the Surgical Operations Register (SLH),
Hospital Activity Analysis (SLH) and records of visual field
examinations. Collected data was analysed using an Excel
spreadsheet and Access database.
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Results
Basic demographic data was collected for 2650 patients. Of
these 1220 were women and 1430 were men, which give female
to male ratio of 1:1.7 (Figure 1).
Age distribution was examined (Figure 2), and clearly
Glaucoma in the Maltese population is exceptional below the
age of 40, after which it starts to increase, reaching a peak at
the age of 75.
Figure 1: Gender Distribution
Figure 2:  Age Distribution
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Detailed clinical data was collected for 874 glaucoma
patients.  These were patients from two Consultants’ firms out
of the five consultants treating ophthalmic patients in the
Government Health Service.
Figure 3 subdivides the 874 patients according the different
aeteological types of glaucoma. The majority of our patients
(83.9%) suffer from Chronic Open Angle Glaucoma, 10.2% have
Acute or Chronic Angle Closure Glaucoma and 5.6 % suffer from
Secondary Glaucoma (mostly of the neovascular type) and the
remaining (0.3%) suffer from Congenital Glaucoma. Cases of
Laser treatment was used in 6% of our patients; Nd YAG
iridotomy was commonly performed in angle closure glaucoma:
the number represents treatment of the eyes after an acute attack
and fellow eyes. No laser iridotomy was performed on the patient
who had no previous acute glaucoma attack.  Argon laser
trabeculoplasty was performed on open angle glaucoma.
The most common surgical intervention performed was
trabeculectomy which was used in 10% of cases. No
antimetabolite was ever used. The modern technique of non-
perforating glaucoma surgery – viscocanaliculostomy - was used
in 1% of our cases, a procedure which was introduced in 2003
at St Luke’s Hospital.Figure 3: Types of Glaucoma in Malta
normal tension glaucoma were included in the Open Angle
Glaucoma group.
Severity of the disease was assessed by the visual field loss
(Figure 4). Of the total number of patients, 38% had no visual
field loss with a cup/disc ratio more then 0.4, 29% had minimal
central visual field loss, 22% moderate and 8% had very severe
Figure 4: Loss of Visual Field
central visual field loss. Glaucoma was the reason of legal
blindness in 3% of our patients.
The different types of treatment were analysed and are
shown in Figure 5. The majority of patients (83%) were
controlled conservatively using mainly topical therapy.
Figure 5: Different Therapies
With regards to the topical therapy, the most commonly
used eye drops for glaucoma were beta-blockers. These are
usually the first line of therapy. This is followed by dorsolamide
and latanoprost. Long term systemic acetazolamide (Diamox)
is still being used by a large number of patients (Figure 6).
The majority of 2650 conservatively treated patients are
controlled by one medication only, but there are 650 patients
who require three or more medications to achieve adequate
control (Figure 7).
Figure 6: Use of different medications
Figure 7: Number of medications per patient
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Discussion
In the Maltese glaucoma population, there is a significantly
higher number of males suffering from glaucoma than females.
This is in agreement with other studies3,4,5  indicating that the
male sex is another risk factor of glaucoma.
Age distribution is very similar to other studies. The number
of glaucoma cases start to increase by the age of 40 and reaches
a peak in the mid-seventies.5
Open angle glaucoma usually represents the absolute
majority of glaucoma types in both Caucasian and black
populations. More than 50% of glaucoma sufferers in the Asian
population have angle closure glaucoma. Our study shows that
90% of the Maltese glaucoma sufferers have of the open angle
type.6,7,8
Glaucoma is a potentially blinding disease. Its outcome is
dependent on early diagnosis, efficient therapy and patient
compliance. There are 3.2% of glaucoma patients who are legally
blind. Most of them are cases of neovascular glaucoma.
About 70% of our patients have minimal and 10% moderate
loss of central visual field. A higher incidence of severe loss of
central visual field is prevented by the Glaucoma screening
program, which allows us to control the disease adequately
before advanced changes develop.
As in other countries, the most common treatment of
glaucoma is based on topical eye drops, with beta blockers being
used as first preference. There are a relatively high number of
people using systemic acetazolamide, a treatment which is
known to have many side effects, especially in the elderly. The
use of more than two topical medications is not very efficient
and might be inconvenient to the patient. We suggest that we
should, in the future, be more rational in the use of drops
combinations.  In the UK there was a decline in glaucoma
surgery owing to the introduction of very efficient modern
topical antiglaucoma medication.9  This is not reflected in Malta
as the number of glaucoma operations has remained steady over
the last 8 years (Table  9).  Furthermore, the use of laser in the
treatment of Glaucoma in Malta Health Service is low in
comparison with other countries, the reason being locally the
lack of modern laser devices required for this kind of treatment.
Conclusion
Glaucoma sufferers on the Maltese Islands have similar
characteristic to glaucoma sufferers in other European
countries. A well conducted screening program allows us to treat
a high number of glaucoma patients before irreversible damage
is done to the eye.
Locally, glaucoma patients are well controlled.  However,
in many cases, multiple  medications are used. A significantly
larger proportion of patients is using long term acetazolamide,
which has undesirable side effects.
It would be beneficial and cost-effective if new laser
equipment were purchased so as to allow the use of transcleral
cyclotherapy, selective trabeculoplasty and other techniques.
Finally, we suggest that more frequent use of laser treatment
and more rational use of topical medication will improve care
of glaucoma patients in Malta.
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Figure 8: Number of Trabeculectomies
